compounded semaglutide crackdown news october 2025 The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the Compounding pharmacies to halt semaglutide

The same principle applies to advanced skincare

While the full mechanism isnt fully mapped out including how its produced or exactly where in the brain it acts the research suggests interesting links to sleep, recovery, hormone release and stress adaptation

You can also book online today

Available from: Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, Kushner R, Rubino DM, Zeuthen N, Verma S

As individuals seek solutions to combat obesity, medications like Wegovy and Mounjaro have gained popularity

Summary of Key Considerations Taking a GLP-1 medication while on blood thinners is a common scenario for many adults today